Inflammatory markers and the risk of coronary heart disease in men and women.

By J. Pai, T. Pischon, Jing Ma, JoAnn E. Manson, S. Hankinson, K. Joshipura, G. Curhan, N. Rifai, C. Cannuscio, MR Stampfer and 1 more. New England Journal of Medicine, 2004

1,250 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/9eb32bf17bdda4464a70797519e4701b50c3e167

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Immunology

In Oncology

J. Kirkland

Citations in the corpus

Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. (2010, background): “Other pro-inflammatory cytokines have also been implicated in CVD, including interleukin (IL)-6 [5] and tumor necrosis factor (TNF)-a [6].”
Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies (2011, background): “Increased levels of inflammatory markers have been associated with risk of cardiovascular disease.”
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005, neutral): “We additionally compared the predictive value of each lipid marker to that of highsensitivity C-reactive protein (CRP), which is an inflammatory biomarker previously shown to predict risk in this(13) and other cohorts.(14-18) To maximize the clinical utility of these data and reduce Author Affilliat”
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality (2009, neutral): “18) 36 49 (22-66) Ischemic strokec Age and sex only 1.”
Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review (2008, background): “Updated Meta-analysis We identified 17 relevant studies [8–21] (including the two current studies, ten newly identified studies [8–13,17,19–21], and five studies [14–16,18] included in the previous published review [22]; flow chart in Figure 1).”
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age (2015, background): “J Gerontol A Biol Sci Med Sci 69(6):621–632.”